对CES1基因和埃纳拉普利尔疗效的药物遗传学研究
Misbah Hussain1, Sehrish Basheer2, Adila Khalil3
1Department of Biotechnology, University of Sargodha, Sagodha, Pakistan. misbahussain@yahoo.com.
Journal of applied genetics
|January 23, 2024
概括
碳氧乙酶1 (CES1) 的遗传变异显著影响埃纳拉普利的新陈代谢和疗效. 了解这些CES1多态性对于个性化医疗和有效的埃纳拉普利治疗至关重要.
科学领域:
- 药物基因组学 药物基因组学
- 酶动力学 酶动力学
- 药物代谢药物代谢
背景情况:
- 埃纳拉普利尔是一种ACE抑制剂,需要由肝脏的碳素酶1 (CES1) 激活,以其活性形式,埃纳拉普利酸.
- CES1在埃纳拉普利的生物转化中起着关键作用,影响其在高血压和心力衰竭中的治疗作用.
- 在CES1基因中的单核酸多态 (SNP) 可以改变酶活性,影响埃纳拉普利的代谢.
研究的目的:
- 审查影响埃纳拉普利尔代谢和临床疗效的CES1多态.
- 讨论CES1催化活性的结构基础和关键氨基酸变化的影响.
- 突出药物基因组学在量身定制埃纳拉普利治疗中的作用.
主要方法:
- 关于CES1基因多态和埃纳拉普利的研究的文献综述.
- 对影响催化活性的CES1SNP报告的分析.
- 讨论CES1酶结构和功能性氨基酸.
主要成果:
- 特定的CES1多态 (G143E,L40T,G142E,G147C,Y170D,R171C) 可以完全抑制埃纳拉普利的新陈代谢.
- 其他多态 (Q169P,E220G,D269fs) 减少了CES1的催化活性.
- 种群特异性CES1多态的流行需要考虑基因背景的Enalapril处方.
结论:
- CES1遗传变异是埃纳拉普利尔药理动力学和药理动力学个体间差异的关键决定因素.
- 以药物基因组学为指导的个性化医疗方法对于优化埃纳拉普利治疗至关重要.
- 了解CES1多态度可以提高埃纳拉普利的疗效和患者的治疗结果.
更多相关视频
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
645
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
645
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:22Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K
01:14Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
734
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
734
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K